Malignancies and catastrophic anti-phospholipid syndrome

Clinical Reviews in Allergy and Immunology

Volumn 36, Issue 2-3, 2009, Pages 91-97

  Miesbach, Wolfgang ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anti phospholipid syndrome; Asherson's syndrome; CAPS; Catastrophic anti phospholipid syndrome; Malignancy; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PROSTACYCLIN; STEROID; PHOSPHOLIPID ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BILE DUCT CARCINOMA; BLOOD CLOT LYSIS; BREAST CANCER; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CHRONIC MYELOMONOCYTIC LEUKEMIA; COLON ADENOCARCINOMA; HEMODIALYSIS; HODGKIN DISEASE; HUMAN; LEIOMYOSARCOMA; LUNG ADENOCARCINOMA; LYMPHOMA; MENINGIOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PERIPHERAL T CELL LYMPHOMA; PLASMAPHERESIS; REGISTER; REVIEW; STOMACH ADENOCARCINOMA; UTERUS CARCINOMA; AGE; BLOOD; BLOOD DISEASE; GERMANY; IMMUNOLOGY; INCIDENCE; PREVALENCE; PROGNOSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE; THROMBOSIS; TREATMENT OUTCOME;

AGE FACTORS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; GERMANY; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMAPHERESIS; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 66349094303     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-008-8101-2     Document Type: Review

References (55)

1. Trousseau A. Phlegmasia alba dolens. In: Clinique Medical de L'Hotel Dieu de Paris Vol 3 London. The New Sydenham Society 1865:94
2. JA Heit MD Silverstein DN et al. Mohr 2000 Risk factors for deep vein thrombosis and pulmonary embolism: a population-based control study Arch Intern Med 160 809 815
3. AY Lee MN Levine 1999 The thrombophilic state induced by therapeutic agents in the cancer patient Semin Thromb Haemost 25 137 145
4. JW Blom CJ Doggen S Osanto 2005 Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 715 722
5. P Prandoni A Falanga A Piccioli 2005 Cancer and venous thromboembolism Lancet Oncology 6 401 410
6. S Schulman P Lindmarker 2000 Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of anticoagulation. Trial N Engl J Med 342 1953 1958
7. M Monreal J Fernandez-Llamazares J Perandreu et al. 1997 Occult cancer in patients with venous thromboembolism: which patients, which cancers Thromb Haemost 78 1316 1318
8. S Miyakis MD Lockshin T Atsumi et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome J Thromb Haemost 4 295 306
9. RA Asherson 2000 Antiphospholipid antibodies, malignancies and paraproteinemias J Autoimmun 15 117 122
10. RA Asherson R Cervera 2000
11. M Kazmierczak K Lewandowski MZ Wojtukiewicz 2005 Cancer proagulant in patients with adenocarcinomas Blood Coagul Fibrinolysis 16 543 537
12. F Langer B Eifrig S Hegewich-Becker 2002 Complicated antiphospholipid syndrome Dtsch Med Wochenschrift 127 1458 1462
13. DP Schreiber DS Kepp 1986 Axillary subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma Int H Radiat Oncol Biol Phys 12 391 395
14. A Ruffatti A Avorsa T Del Ross et al. 1994 Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome J Rheumatol 21 2162 2163
15. CL Kozlowski MJ Johnson DW Gorst et al. 1987 Lung cancer, immune thrombocytopenia and the lupus inhibitor Postgrad Med 63 793 795
16. A Papagiannis A Cooper J Bans 1994 Pulmonary embolism and lupus anticoagulant in a woman with renal cell carcinoma J Urol 152 941 942
17. CJ Park HI Gho SI Kim 1991 A study of changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma J Korean Med Sol 6 1 6
18. RA Asherson D D'Cruz 2007 Vascular occlusions in a patient with low positive antiphospholipid antibodies and subsequent development of breast carcinoma: a diagnostic dilemma Clin Rheumatol 26 1531 1533
19. R Stasi E Stipa M Masi F Oliva A Sciarra A Perrotti G Zaccari G Papa 1993 Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Thromb Haemost 70 568 572
20. UH Athale AK Chan 2003 Thrombosis in children with lymphoblastic leukemia Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment Thromb Res 111 321 327
21. H Mouas O Lortholary V Eclache et al. 1994 Antiphospholipid syndrome during acute monocytic leukemia Eur J Haematol 53 59 60
22. A Orsino R Schneider G DeVeber et al. 2004 Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid syndrome J Pedriatr Hematol Oncol 26 327 330
23. E Zuckerman E Toubi T Golan et al. 1995 Increased thromboembolic incidence in anticardiolipin-positive patients with malignancy Br J Cancer 72 447 451
24. S Pusterla S Previtali S Marziali et al. 2004 Antiphospholipid antibodies in lymphoma: prevalence and clinical significance Hematol J 5 341 346
25. I Genvresse D Lüftner E Späth-Schwalbe F Buttgereit 2002 Prevelance and clinical significance of anticardiolipin and anti-ß2- glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma Eur J Haematol 68 84 90
26. KH Yoon A Wong T Shakespeare P Sivalingham 2003 High prevalence of the antiphospholipid antibodies in Asian cancer patients with thrombosis Lupus 12 112 116
27. JA Gomez-Puerta R Cervera G Espinosa et al. 2006 Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients Semin Arthritis Rheum 35 322 332
28. W Miesbach I Scharrer RA Asherson 2006 Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies Clin Rheumatol 25 1 5
29. W Miesbach I Scharrer RA Asherson 2007 High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma Clin Rheumatol 26 95 97
30. JF Schved C Dupuy-Fons C Biron et al. 1994 A prospective epdimiological study of the occurrence of antiphospholipid antibody; the Montpelier Antiphospholipid (MAP) Study Haemostasis 24 175 182
31. J-C Piette R Cervera RA Levy EL Nasonov DA Triplett Y Shoenfeld 2000 The catastrophic antiphospholipid syndrome-Asherson's syndrome Ann Med Interne 154 195 196
32. Y Shoenfeld R Cervera 2008 Asherson's syndrome of the catastrophic antiphospholipid antibodies J Rheumatol 35 10 2066 2068
33. RA Asherson R Cervera PG de Groot D Erkan M-C Boffa JC Piett 2003 Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines Lupus 12 530 534
34. Cervera R, Gómez-Puerta JA, Espinosa G, Font J, De la Red G, Gil V, Bucciarelli S et al (2003) "CAPS Registry". A review of 200 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS) Ann Rheum Dis OP0075
35. RA Asherson 1992 The catastrophic antiphospholipid syndrome J Rheumatol 19 4 508 512
36. S Bucciarelli G Espinosa R Cervera et al. 2006 Mortality in the catastrophic antiphospholipid syndrome Arth Rheum 54 2568 2576
37. RA Asherson 2005 Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome Immunobiology 210 727 733
38. W Miesbach RA Asherson R Cervera Y Shoenfeld J Gomez Puerta G Espinosa S Bucciarelli 2007 Members of the CAPS Registry Group. The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome Clin Rheumatol 26 12 2109 2114
39. R Cervera RA Asherson ML Acevedo JA Gómez-Puerta G Espinosa G De La Red V Gil M Ramos-Casals M Garcia-Carrasco M Ingelmo J Fontr 2004 Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients Ann Rheum Dis 63 10 1312 1317
40. R Cervera JA Gómez-Puerta G Espinosa J Font G De La Red V Gil S Bucciarelli et al. 2003 "CAPS registry". A review of 200 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS) Ann Rheum Dis 62 Suppl 1 88
41. H Amital Y Levy C Davidson I Lundberg A Harju Y Kosach RA Asherson Y Shoenfeld 2001 Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases Semin Arthritis Rheum 31 2 127 132
42. RA Asherson MC Davidge-Pitts E Wypkema 2006 "Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: a case report Clin Rheumatol 26 2 278 280
43. RA Asherson C Frances L Iaccarino MA Khamashta F Malacarne JC Piette A Tincani A Doria 2006 The antiphospholipid antibody syndrome: diagnosis, skin Clin Exp Rheumatol 24 1 Suppl 40 S46 S51
44. S Pusterla S Previtali S Marziali et al. 2004 Antiphospholipid antibodies in lymphoma: prevalence and clinical significance Hematol J 5 4 341 346
45. I Genvresse D Lüftner E Späth-Schwalbe F Buttgereit 2002 Prevalence and clinical significance of anticardiolipin and anti-β2- glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma Eur J Haematol 68 2 84 90
46. A Timuragaoglu A Duman G Ongut O Saka I Karadogan 2000 The significance of autoantibodies in non-Hodgkin's lymphoma Leuk Lymphoma 40 1 119 122
47. H Manner B Jung L Tonassi et al. 2008 Successful treatment of catastrophic antiphospholipid syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine Am J Med Ci 335 394 397
48. RA Asherson G Espinosa S Menahem et al. 2008 Relapsing catastrophic antiphsopholipid syndrome: report of three cases Semin Arthristis Rheum 37 366 372
49. S Deane FJ Meyers ME Gershwin 2008 On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years J Autoimmun 30 180 196
50. EJ Boren GS Cheema SM Naguwa AA Ansari ME Gershwin 2008 The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases J Autoimmmun 30 90 98
51. P Ghia C Scielzo M Frenquelli M Muzio F Caligaris-Cappio 2007 From normal to clonal B cells: chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity Autoimmun Rev 7 127 131
52. G Ferraccioli B Tolusso 2007 Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings Autoimmun Rev 7 109 113
53. N Gleicher D Barad A Weghofer 2007 Functional autoantibodies, a new paradigm in autoimmunity Autoimmun Rev 7 42 45
54. HP Vollmers S Brarndlein 2007 Natural antibodies and cancer J Autoimmun 29 295 302
55. T Akatsuka N Kobayashi T Ishikawa T Saito M Shindo M Yamauchi et al. 2007 Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A J Autoimmun 28 7 18